Infrapatellar Fat Pad Preservation Versus Resection on Clinical Outcomes After Total Knee Arthroplasty(IPAKA)
NCT ID: NCT03763448
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
377 participants
INTERVENTIONAL
2018-12-17
2024-05-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Medially Pedicled IPFP flap in TKA
NCT06704776
Total Fat Pad Excision Leads to Worse Isokinetic Performance in Total Knee Arthroplasty
NCT04419142
Infrapatellar Fat Pad Excision in Total Knee Arthroplasty
NCT05060536
Patients With Higher BMI Produces More Postoperative Drainage Volume and Length of Stay in Cross-Sectional Study
NCT05998538
Surgical Excision of the Fat Pad
NCT04503512
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The IPFP is a fat mass located behind the patellar ligament, between the lower part of the patella and the tibial tubercle. The function of IPFP is controversial at present. It is reported that IPFP can provide blood supply for anterior cruciate ligament, patella and patellar ligament through the arterial network of the knee joint. In addition, it can fill the joint gap to lubricate the surface of the joint, reduce friction and absorb impulse so as to play a physiological protective role. On the contrary, studies have pointed out that abnormal IPFP could produce various pro-inflammatory cytokines such as interleukin (IL)-1β, tumour necrosis factor (TNF)-α, IL-6 and IL-8, as well as adipokines such as leptin and resistin, and thus might play a detrimental role in knee OA. Traditionally, the IPFP has been removed in order to improve surgical exposure and to prevent interposition during baseplate implantation. Despite the significant evolution of TKA technology which no longer requires the resection of IPFP for better surgical access, IPFP is still partially or totally resected in around 88% of TKAs.
The investigators' previous population-based cohort study revealed that IPFP maximal area and volume were associated with reduced knee pain, decreased loss of cartilage volume and reduced risks of cartilage defect progression, indicating a beneficial effect of IPFP size. On the other hand, the investigators' further investigation demonstrated that IPFP signal intensity alteration was negatively associated with maximum area of IPFP, and moreover, associated with increased knee cartilage defects, subchondral bone marrow lesion (BML) and knee pain, suggesting IPFP with abnormal quality may play a detrimental role in knee OA. Based on these findings, the investigators proposed that IPFP with normal quality should be preserved or not damaged during TKA, while IPFP with abnormal quality should be resected. This multicentre randomised controlled trial is designed to test the investigators' hypotheses: in patients with normal IPFP quality, preservation of IPFP during TKA procedure will reduce postoperative knee symptoms and improve joint function, comparing with IPFP resection during TKA procedures; in patients with abnormal IPFP quality, resection of IPFP during TKA procedure will reduce postoperative knee symptoms and improve joint function, comparing with IPFP preservation during TKA procedures. The results would provide evidence-based recommendations on clinical practice to improve OA patients' postoperative outcomes.
Three hundred and sixty eligible participants will be recruited and identified as having normal IPFP quality (signal intensity alteration score ≤ 1) or abnormal IPFP quality (signal intensity alteration score ≥ 2). Participants in each site will be randomly allocated to IPFP resection group or preservation group using computer-generated block randomisation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infrapatellar Fat Pad Preservation
The IPFP retention of more than 80% in actual operation shall be regarded as IPFP retention.
Infrapatellar Fat Pad preservation
In the IPFP preservation group, IPFP (more than 80%) will be preserved by retracting out of the operative field.
Infrapatellar Fat Pad Resection
In the clinical practice, more than 80% of IPFP volume is commonly resected by surgeons during total knee arthroplasty. The investigators hereby define resection of more than 80% IPFP volume as IPFP excision.
Infrapatellar Fat Pad resection
In the IPFP resection group, more than 80% IPFP will be resected during the total knee arthroplasty.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infrapatellar Fat Pad preservation
In the IPFP preservation group, IPFP (more than 80%) will be preserved by retracting out of the operative field.
Infrapatellar Fat Pad resection
In the IPFP resection group, more than 80% IPFP will be resected during the total knee arthroplasty.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The need for TKA was confirmed after evaluation by the orthopedic surgeon
* One week before surgery, knee pain 100mm pain visual analogue scale score was greater than 20mm
* Understanding of the study requirements and willing to participate in this study
Exclusion Criteria
* Requiring contralateral TKA within one year
* The visual analogue score of 100mm of knee pain before operation was less than 20mm
* Having a possible or planned pregnancy
* With poor compliance
* Suffering from somatic disease, psychiatric or cognitive disorders, neurological disorders that will compromise the safety, compliance, consent, participation, follow-up and the interpretation of the results
* Severe knee valgus
* Contraindications with TKA or MRI
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tianjin Hospital
OTHER
Peking University People's Hospital
OTHER
The First Affiliated Hospital of Anhui Medical University
OTHER
First Affiliated Hospital of Jinan University
OTHER
Anhui Provincial Hospital
OTHER_GOV
Youjiang Medical College for Nationalities
OTHER
Xiangya Hospital of Central South University
OTHER
Zhujiang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ding Changhai
Director,Clinical Research Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Changhai Ding, MD
Role: PRINCIPAL_INVESTIGATOR
Clinical Research Center of Zhujiang Hospital,Southern Medical University
Jianhao Lin, MD
Role: PRINCIPAL_INVESTIGATOR
Peking University People's Hospital
Xisheng Weng, MD
Role: PRINCIPAL_INVESTIGATOR
Peking Union Medical College Hospital
Guanghua Lei, MD
Role: PRINCIPAL_INVESTIGATOR
Xiangya Hospital of Central South University
Zongsheng Yin, MD
Role: PRINCIPAL_INVESTIGATOR
The First Affiliated Hospital of Anhui Medical University
Zhengang Zha, MD
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital of Jinan University
Jing Tian, MD
Role: PRINCIPAL_INVESTIGATOR
Zhujiang Hospital
Xifu Shang, MD
Role: PRINCIPAL_INVESTIGATOR
Anhui Provincial Hospital
Yujin Tang, MD
Role: PRINCIPAL_INVESTIGATOR
Youjiang Medical College for Nationalities
Jun Liu, MD
Role: PRINCIPAL_INVESTIGATOR
Tianjin Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhujiang Hospital
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zhu Z, Han W, Lu M, Lin J, Yin Z, Shang X, Weng X, Zha Z, Tian J, Lei G, Hunter DJ, Ding C. Effects of infrapatellar fat pad preservation versus resection on clinical outcomes after total knee arthroplasty in patients with knee osteoarthritis (IPAKA): study protocol for a multicentre, randomised, controlled clinical trial. BMJ Open. 2020 Oct 23;10(10):e043088. doi: 10.1136/bmjopen-2020-043088.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-GJGBK-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.